Congress does not pass 'most favored nation' drug pricing law

Market overview

Legislation resembling the 'most favored nation' drug pricing policy fails to pass Congress before 2027. Industry opposition and Republican concerns prevent its adoption.

regulatory prediction market

Implied probability (Yes)

80%

Source: user-generated

More regulatory markets

• Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
• Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
• Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
• Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
• Harborne crypto holdings face regulatory scrutiny — 60% Yes
• SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
• SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
• Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes

Browse all regulatory markets →